ArticlePloS one2020

Will prior health insurance authorization for medications continue to hinder hepatitis C treatment delivery in the United States? Perspectives from hepatitis C treatment providers in a large urban healthcare system.

Marjan Javanbakht et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.